Crispr Therapeutics

Crispr Therapeutics is a biotechnology company that focuses on developing transformative gene-editing therapies for treating diseases based on the CRISPR-Cas9 technology. The company's mission is to revolutionize the treatment of human diseases by harnessing the power of the CRISPR-Cas9 system to develop therapies that can cure, prevent, or treat a wide range of diseases. Crispr Therapeutics has a strong pipeline of gene-editing therapies in various stages of development, including treatments for sickle cell anemia, muscular dystrophy, and Huntington's disease. The company is committed to advancing the field of gene editing and improving the lives of patients around the world.